TS
Terry Smith (Fundsmith) disclosed decreased in CATALYST PHARMACEUTICALS INC
Terry Smith (Fundsmith) filed a 13F change in CATALYST PHARMACEUTICALS INC (14888U101) on 2026-05-15, covering period end 2026-03-31.
Action
Decreased
Capital
$57,591,853 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.